Monopar Therapeutics (MNPR) Profit After Tax Growth (1y) (2018 - 2025)
Monopar Therapeutics (MNPR) Profit After Tax Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 111.59% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -168.61% |
| Jun 30, 2025 | -43.04% |
| Mar 31, 2025 | -59.94% |
| Sep 30, 2024 | 33.35% |
| Jun 30, 2024 | 22.03% |
| Mar 31, 2024 | 32.59% |
| Sep 30, 2023 | 17.57% |
| Jun 30, 2023 | 20.37% |
| Mar 31, 2023 | 0.90% |
| Dec 31, 2022 | -7.68% |
| Sep 30, 2022 | 3.43% |
| Jun 30, 2022 | -4,847,147.37% |
| Mar 31, 2022 | -30.40% |
| Dec 31, 2021 | -25.85% |
| Sep 30, 2021 | -50.09% |
| Jun 30, 2021 | 100.00% |
| Mar 31, 2021 | -72.71% |
| Dec 31, 2020 | -76.54% |
| Sep 30, 2020 | -119.91% |
| Jun 30, 2020 | -59.63% |